What's breaking now, across thousands of outlets.
Musician, who revealed first Hodgkin's lymphoma diagnosis in 2013, says cancer's return won't slow him down
We haven't written up this one. Rolling Stone has the full story — the link below goes straight to it.
The clearance of Genglycos for a rare glycogen storage disease gives Ultragenyx a sellable voucher and momentum ahead of an eagerly anticipated study readout.
Die Börse feiert den Studienerfolg von Moderna und Merck. Ein personalisierter Krebsimpfstoff rückt näher und könnte ein Gamechanger für die Krebsmedizin werden.
There is no cure for dementia, and as the condition progresses, the patient may not be able to recognize loved ones.
Moderna gained $45 billion in market value in a single day, a surge that brought the company’s stock to levels not seen since 2024 — and saddled it with expectations that may be tough to meet.
Mumbai: The Brihanmumbai Municipal Corporation (BMC) on Thursday undertook a technology-based initiative to introduce QR code-enabled reflective collars for stray dogs in Mumbai, aimed at making the…
